Position in ABBV
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$7,657,153
+$974,556 QoQ
Shares Held
30,429
-1.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.68%
of 13F equity value
Holder Rank
#1,053
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DELTA ASSET MANAGEMENT LLC/TN holds $27,667,664 across 14 Drug Manufacturers - General names. ABBV ranks #2 (27.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
40,142 | $10,194,863 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
30,429 | $7,657,153 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
75,264 | $4,336,711 | |
| 4 | PFE |
Pfizer Inc
|
105,462 | $2,539,524 | |
| 5 | MRK |
Merck & Co., Inc.
|
12,334 | $1,584,919 | |
| 6 | LLY |
ELI LILLY & Co
|
671 | $804,817 | |
| 7 | AMGN |
Amgen Inc
|
999 | $361,757 | |
| 8 | GSK |
GSK plc
|
2,138 | $112,073 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,657,153 | 30,429 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $6,682,597 | 30,726 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $7,103,754 | 31,090 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $7,571,126 | 32,699 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $6,077,198 | 32,740 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $6,919,188 | 33,024 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $6,367,879 | 35,835 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $7,350,798 | 37,223 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $6,590,656 | 38,425 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $7,084,236 | 38,903 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $6,154,323 | 39,713 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $6,061,823 | 40,667 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $5,453,466 | 40,477 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $6,474,884 | 40,628 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $6,044,375 | 37,401 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $5,008,448 | 37,318 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $5,666,154 | 36,995 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $6,018,657 | 37,127 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $4,707,451 | 34,767 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $3,326,926 | 30,842 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $3,128,125 | 27,771 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $1,802,079 | 16,652 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $1,138,683 | 10,627 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $693,012 | 7,912 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $776,800 | 7,912 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $620,338 | 8,142 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||